Jump to content Main menu Main menu move to sidebar hide Navigation Main page Contents Current events Random article About Wikipedia Contact us Contribute Help Learn to edit Community portal Recent changes Upload file Special pages Search Search Appearance Donate Create account Log in Personal tools Donate Create account Log in Pages for logged out editors learn more Contributions Talk CentralNotice Contents move to sidebar hide (Top) 1 Medical uses 2 Pharmacology Toggle Pharmacology subsection 2.1 Pharmacodynamics 3 Biosynthesis 4 Toxicology Toggle Toxicology subsection 4.1 Mice 5 References Toggle the table of contents Griseofulvin 25 languages العربية تۆرکجه Cymraeg Deutsch Español فارسی Français 한국어 Bahasa Indonesia Italiano עברית Magyar Bahasa Melayu 日本語 Norsk nynorsk ଓଡ଼ିଆ Polski Português Română Српски / srpski Srpskohrvatski / српскохрватски Suomi Українська Tiếng Việt 中文 Edit links Article Talk English Read Edit View history Tools Tools move to sidebar hide Actions Read Edit View history General What links here Related changes Upload file Permanent link Page information Cite this page Get shortened URL Download QR code Print/export Download as PDF Printable version In other projects Wikimedia Commons Wikidata item Appearance move to sidebar hide From Wikipedia, the free encyclopedia Antifungal medication used for dermatophytoses Pharmaceutical compound Griseofulvin Clinical data Trade names Gris-peg, Grifulvin V, others AHFS / Drugs.com Monograph MedlinePlus a682295 Pregnancy category AU : D Routes of administration By mouth ATC code D01AA08 ( WHO ) D01BA01 ( WHO ) Legal status Legal status AU : S4 (Prescription only) UK : POM (Prescription only) US : ℞-only Pharmacokinetic data Bioavailability Highly variable (25 to 70%) Metabolism Liver ( demethylation and glucuronidation ) Elimination half-life 9–21 hours Identifiers IUPAC name (2 S ,6' R )- 7-chloro- 2',4,6-trimethoxy- 6'-methyl- 3 H ,4' H -spiro [1-benzofuran- 2,1'-cyclohex[2]ene]- 3,4'-dione CAS Number 126-07-8 Y PubChem CID 441140 DrugBank DB00400 Y ChemSpider 389934 Y UNII 32HRV3E3D5 KEGG D00209 Y ChEBI CHEBI:27779 Y ChEMBL ChEMBL562 Y CompTox Dashboard ( EPA ) DTXSID8020674 ECHA InfoCard 100.004.335 Chemical and physical data Formula C 17 H 17 Cl O 6 Molar mass 352.77 g·mol −1 3D model ( JSmol ) Interactive image SMILES O=C2c3c(O[C@@]21C(/OC)=C\C(=O)C[C@H]1C)c(Cl)c(OC)cc3OC InChI InChI=1S/C17H17ClO6/c1-8-5-9(19)6-12(23-4)17(8)16(20)13-10(21-2)7-11(22-3)14(18)15(13)24-17/h6-8H,5H2,1-4H3/t8-,17+/m1/s1 Y Key:DDUHZTYCFQRHIY-RBHXEPJQSA-N Y (verify) Griseofulvin is an antifungal medication used to treat dermatophytoses (ringworm).

[ 1 ] [ 2 ] This includes fungal infections of the nails and scalp, as well as the skin when antifungal creams have not worked.

[ 3 ] It is taken by mouth.

[ 2 ] Common side effects include allergic reactions , nausea , diarrhea , headache, trouble sleeping, and feeling tired.

[ 2 ] It is not recommended in people with liver failure or porphyria .

[ 2 ] Use during or in the months before pregnancy may result in harm to the baby.

[ 2 ] [ 3 ] Griseofulvin works by interfering with fungal mitosis .

[ 1 ] [ 2 ] Griseofulvin was discovered in 1939 from the soil fungus Penicillium griseofulvum .

[ 4 ] [ 5 ] [ 6 ] It is on the World Health Organization's List of Essential Medicines .

[ 7 ] Medical uses [ edit ] Griseofulvin is used orally only for dermatophytosis . It is ineffective topically. It is reserved for cases in which topical treatment with creams is ineffective.

[ 8 ] Terbinafine given for 2 to 4 weeks is at least as effective as griseofulvin given for 6 to 8 weeks for treatment of Trichophyton scalp infections. However, griseofulvin is more effective than terbinafine for treatment of Microsporum scalp infections.

[ 9 ] [ 10 ] Pharmacology [ edit ] Pharmacodynamics [ edit ] The drug binds to tubulin , interfering with microtubule function, thus inhibiting mitosis .

[ 11 ] It binds to keratin in keratin precursor cells and makes them resistant to fungal infections. The drug reaches its site of action only when hair or skin is replaced by the keratin-griseofulvin complex. Griseofulvin then enters the dermatophyte through energy-dependent transport processes and binds to fungal microtubules. This alters the processing for mitosis and also underlying information for deposition of fungal cell walls.

[ citation needed ] Biosynthesis [ edit ] It is produced industrially by fermenting the fungus Penicillium griseofulvum .

[ 12 ] [ 13 ] [ 14 ] The first step in the biosynthesis of griseofulvin by P. griseofulvin is the synthesis of the 14-carbon poly-β-keto chain by a type I iterative polyketide synthase (PKS) via iterative addition of 6 malonyl-CoA to an acyl-CoA starter unit. The 14-carbon poly-β-keto chain undergoes cyclization/aromatization, using cyclase/aromatase, respectively, through a Claisen and aldol condensation to form the benzophenone intermediate. The benzophenone intermediate is then methylated via S -adenosyl methionine (SAM) twice to yield griseophenone C. The griseophenone C is then halogenated at the activated site ortho to the phenol group on the left aromatic ring to form griseophenone B. The halogenated species then undergoes a single phenolic oxidation in both rings forming the two oxygen diradical species. The right oxygen radical shifts alpha to the carbonyl via resonance allowing for a stereospecific radical coupling by the oxygen radical on the left ring forming a tetrahydrofuranone species.

[ 15 ] The newly formed grisan skeleton with a spiro center is then O -methylated by SAM to generate dehydrogriseofulvin. Ultimately, a stereoselective reduction of the olefin on dehydrogriseofulvin by NADPH affords griseofulvin.

[ 16 ] [ 17 ] Toxicology [ edit ] Mice [ edit ] Griseofulvin is found to alter the bile metabolism of mice by Yokoo et al. 1979. The same team went on to find a similar effect on mice by a chemically unrelated substance, 3,5-diethoxycarbonyl-1,4-dihydrocollidine , in Yokoo et al. 1982 and Tsunoo et al. 1987.

[ 18 ] References [ edit ] ^ a b K. Gull , A. P. Trinci (1 August 1973).

"Griseofulvin inhibits Fungal Mitosis" .

Nature .

244 (5414): 292– 294.

doi : 10.1038/244292A0 .

ISSN 1476-4687 .

PMID 4583105 .

Wikidata Q53705508 .

^ a b c d e f "Griseofulvin" . The American Society of Health-System Pharmacists.

Archived from the original on 20 December 2016 . Retrieved 8 December 2016 .

^ a b World Health Organization (2009). Stuart MC, Kouimtzi M, Hill SR (eds.).

WHO Model Formulary 2008 . World Health Organization. p. 149.

hdl : 10665/44053 .

ISBN 9789241547659 .

^ Block SS (2001).

Disinfection, Sterilization, and Preservation . Lippincott Williams & Wilkins. p. 631.

ISBN 9780683307405 .

Archived from the original on 20 December 2016.

^ Ash M, Ash I (2004).

Handbook of Preservatives . Synapse Info Resources. p. 406.

ISBN 978-1-890595-66-1 .

Archived from the original on 31 December 2013.

^ Beekman AM, Barrow RA (2014). "Fungal metabolites as pharmaceuticals".

Australian Journal of Chemistry .

67 (6): 827– 843.

doi : 10.1071/ch13639 .

^ World Health Organization (2019).

World Health Organization model list of essential medicines: 21st list 2019 . Geneva: World Health Organization.

hdl : 10665/325771 . WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.

^ Mutschler E, Schäfer-Korting M (2001).

Arzneimittelwirkungen (in German) (8 ed.). Stuttgart: Wissenschaftliche Verlagsgesellschaft. p. 838.

ISBN 3-8047-1763-2 .

^ Fleece D, Gaughan JP, Aronoff SC (November 2004). "Griseofulvin versus terbinafine in the treatment of tinea capitis: a meta-analysis of randomized, clinical trials".

Pediatrics .

114 (5): 1312– 1315.

doi : 10.1542/peds.2004-0428 .

PMID 15520113 .

S2CID 34976866 .

^ Chen X, Jiang X, Yang M, González U, Lin X, Hua X, et al. (May 2016).

"Systemic antifungal therapy for tinea capitis in children" .

The Cochrane Database of Systematic Reviews .

2016 (5): CD004685.

doi : 10.1002/14651858.CD004685.pub3 .

PMC 8691867 .

PMID 27169520 .

^ Aris P, Wei Y, Mohamadzadeh M, Xia X (October 2022).

"Griseofulvin: An Updated Overview of Old and Current Knowledge" .

Molecules .

27 (20): 7034.

doi : 10.3390/molecules27207034 .

PMC 9610072 .

PMID 36296627 .

^ Oxford AE, Raistrick H, Simonart P (February 1939).

"Studies in the biochemistry of micro-organisms: Griseofulvin, C(17)H(17)O(6)Cl, a metabolic product of Penicillium griseo-fulvum Dierckx" .

The Biochemical Journal .

33 (2): 240– 248.

doi : 10.1042/bj0330240 .

PMC 1264363 .

PMID 16746904 .

^ Grove JF, Ismay D, Macmillan J, Mulholland TP, Rogers MA (1951). "The structure of griseofulvin".

Chemistry and Industry .

11 . London: 219– 220.

^ Grove JF, MacMillan J, Mulholland TP, Rogers MA (1952). "762. Griseofulvin. Part IV. Structure".

Journal of the Chemical Society (Resumed) : 3977.

doi : 10.1039/JR9520003977 .

^ Birch A (1953). "Studies in relation to biosynthesis I. Some possible routes to derivatives of orcinol and phloroglucinol".

Australian Journal of Chemistry .

6 (4): 360.

doi : 10.1071/ch9530360 .

^ Dewick PM (2009).

Medicinal Natural Products: A Biosynthetic Approach (3rd ed.) . UK: John Wiley & Sons Ltd.

ISBN 978-0-471-97478-9 .

^ Harris CM, Roberson JS, Harris TM (August 1976). "Biosynthesis of griseofulvin".

Journal of the American Chemical Society .

98 (17): 5380– 5386.

Bibcode : 1976JAChS..98.5380H .

doi : 10.1021/ja00433a053 .

PMID 956563 .

^ Knasmüller S, Parzefall W, Helma C, Kassie F, Ecker S, Schulte-Hermann R (September 1997). "Toxic effects of griseofulvin: disease models, mechanisms, and risk assessment".

Critical Reviews in Toxicology .

27 (5).

Taylor & Francis : 495– 537.

doi : 10.3109/10408449709078444 .

PMID 9347226 .

v t e Antifungals ( D01 and J02 ) Wall/ membrane Ergosterol inhibitors Azoles ( lanosterol 14α- demethylase inhibitors) Imidazoles Topical: bifonazole ‡ butoconazole chlormidazole ‡ climbazole clotrimazole # croconazole ‡ eberconazole econazole fenticonazole ‡ flutrimazole isoconazole ketoconazole luliconazole miconazole # neticonazole ‡ omoconazole ‡ oxiconazole sertaconazole sulconazole tioconazole Systemic: ketoconazole Triazoles Topical: efinaconazole fluconazole # terconazole Systemic: fluconazole # fosfluconazole fosravuconazole hexaconazole ‡ isavuconazole itraconazole # oteseconazole posaconazole voriconazole # Unknown: albaconazole ‡ ravuconazole † Thiazoles Topical: abafungin ‡ Polyene antimycotics ( ergosterol binding) Topical: hamycin ‡ natamycin nystatin # Systemic: amphotericin B # , hamycin ‡ Squalene monooxygenase inhibitors Allylamines Topical: naftifine terbinafine Systemic: terbinafine Benzylamines Topical: butenafine Others Topical: amorolfine β-glucan synthase inhibitors Systemic: echinocandins ( anidulafungin caspofungin cilofungin micafungin rezafungin ) ibrexafungerp Intracellular Pyrimidine analogues / thymidylate synthase inhibitors Systemic: flucytosine # Mitotic inhibitors Systemic: griseofulvin # Aminoacyl tRNA synthetase inhibitors Topical: tavaborole Others bromochlorosalicylanilide chlorophetanol chlorphenesin ciclopirox crystal violet dimazole ethylparaben haloprogin ‡ polynoxylin potassium iodide # salicylic acid selenium disulfide # sodium thiosulfate # sulbentine taurolidine ticlatone tolciclate tolnaftate tribromometacresol undecylenic acid Whitfield's ointment # citronella oil lemon grass lemon myrtle orange oil patchouli tea tree oil PCP : atovaquone dapsone pentamidine # WHO-EM ‡ Withdrawn from market Clinical trials : † Phase III § Never to phase III v t e Xenobiotic-sensing receptor modulators CAR Tooltip Constitutive androstane receptor Agonists: 6,7-Dimethylesculetin Amiodarone Artemisinin Benfuracarb Carbamazepine Carvedilol Chlorpromazine Chrysin CITCO Clotrimazole Cyclophosphamide Cypermethrin DHEA ( prasterone ) Efavirenz Ellagic acid Griseofulvin Methoxychlor Mifepristone Nefazodone Nevirapine Nicardipine Octicizer Permethrin Phenobarbital Phenytoin Pregnanedione (5β-dihydroprogesterone) Reserpine TCPOBOP Telmisartan Tolnaftate Troglitazone Valproic acid Antagonists: 3,17β-Estradiol 3α-Androstanol 3α-Androstenol 3β-Androstanol 17-Androstanol AITC Ethinylestradiol Meclizine Nigramide J Okadaic acid PK-11195 S-07662 T-0901317 PXR Tooltip Pregnane X receptor Agonists: 17α-Hydroxypregnenolone 17α-Hydroxyprogesterone Δ 4 -Androstenedione Δ 5 -Androstenediol Δ 5 -Androstenedione AA-861 Allopregnanediol Allopregnanedione (5α-dihydroprogesterone) Allopregnanolone (brexanolone) Alpha-Lipoic acid Ambrisentan AMI-193 Amlodipine besylate Antimycotics Artemisinin Aurothioglucose Bile acids Bithionol Bosentan Bumecaine Cafestol Cephaloridine Cephradine Chlorpromazine Ciglitazone Clindamycin Clofenvinfos Chloroxine Clotrimazole Colforsin Corticosterone Cyclophosphamide Cyproterone acetate Demecolcine Dexamethasone DHEA ( prasterone ) DHEA-S ( prasterone sulfate ) Dibunate sodium Diclazuril Dicloxacillin Dimercaprol Dinaline Docetaxel Docusate calcium Dodecylbenzenesulfonic acid Dronabinol Droxidopa Eburnamonine Ecopipam Enzacamene Epothilone B Erythromycin Famprofazone Febantel Felodipine Fenbendazole Fentanyl Flucloxacillin Fluorometholone Griseofulvin Guggulsterone Haloprogin Hetacillin potassium Hyperforin Hypericum perforatum (St John's wort) Indinavir sulfate Lasalocid sodium Levothyroxine Linolenic acid: α-Linolenic acid and γ-Linolenic acid LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine Nisoldipine Norelgestromin Omeprazole Orlistat Oxatomide Paclitaxel Phenobarbital Piperine Plicamycin Prednisolone Pregnanediol Pregnanedione (5β-dihydroprogesterone) Pregnanolone Pregnenolone Pregnenolone 16α-carbonitrile Proadifen Progesterone Quingestrone Reserpine Reverse triiodothyronine Rifampicin Rifaximin Rimexolone Riodipine Ritonavir Simvastatin Sirolimus Spironolactone Spiroxatrine SR-12813 Suberoylanilide Sulfisoxazole Suramin Tacrolimus Tenylidone Terconazole Testosterone isocaproate Tetracycline Thiamylal sodium Thiothixene Thonzonium bromide Tianeptine Troglitazone Troleandomycin Tropanyl 3,5-dimethulbenzoate Zafirlukast Zeranol Antagonists: Ketoconazole Sesamin See also Receptor/signaling modulators Portal : Medicine Retrieved from " https://en.wikipedia.org/w/index.php?title=Griseofulvin&oldid=1301729622 " Categories : Antifungals Aromatic ketones Chloroarenes Cyclohexenes Disulfiram-like drugs Halogen-containing natural products IARC Group 2B carcinogens Mutagens Resorcinol ethers Spiro compounds World Health Organization essential medicines Terpenes and terpenoids Enol ethers Hidden categories: CS1:Vancouver names with accept markup CS1 German-language sources (de) Articles with short description Short description matches Wikidata Use dmy dates from March 2024 Short description is different from Wikidata ECHA InfoCard ID from Wikidata Drugboxes which contain changes to watched fields All articles with unsourced statements Articles with unsourced statements from December 2022 Wikipedia medicine articles ready to translate This page was last edited on 21 July 2025, at 10:38 (UTC) .

Text is available under the Creative Commons Attribution-ShareAlike 4.0 License ;
additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy . Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.

, a non-profit organization.

Privacy policy About Wikipedia Disclaimers Contact Wikipedia Code of Conduct Developers Statistics Cookie statement Mobile view Search Search Toggle the table of contents Griseofulvin 25 languages Add topic

